Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% | 0.00% | +20.00% |
02-28 | NAVCO Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Sales 2022 | 58.73K 43.16K | Sales 2023 | - | Capitalization | 1.21M 890K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -1.47M | EV / Sales 2022 * | - |
Net Debt 2022 | 896K 659K | Net Debt 2023 | 370K 272K | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.42
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Current month | -14.29% | ||
1 month | +20.00% | ||
6 months | -25.00% | ||
Current year | +20.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.03 | 0.00% | 2,059 |
Delayed Quote Toronto S.E., May 13, 2024 at 09:30 am
More quotes1st Jan change | Capi. | |
---|---|---|
+20.00% | 1.25M | |
+13.63% | 391B | |
+13.16% | 135B | |
+18.59% | 77.59B | |
-12.83% | 66.1B | |
-7.01% | 48.07B | |
-4.60% | 39.5B | |
+6.41% | 35.12B | |
+10.36% | 18.18B | |
+14.18% | 16.01B |
- Stock Market
- Equities
- NAV Stock